Abstract
A mouse pituitary tumor cell line (AtT-20) releases corticotropin (ACTH) in response to a number of secretagogues, including corticotropin-releasing factor (CRF), beta-adrenergic agents, N6,O2'-dibutyryladenosine 3',5'-cyclic monophosphate (Bt2 cAMP), and potassium. The stimulation of ACTH secretion induced by the secretagogues can be blocked by inhibitors of the enzymes that generate (phospholipase A2) and metabolize (lipoxygenase and epoxygenase) arachidonic acid. The phospholipase A2 blockers mepacrine and p-bromophenacylbromide inhibited the ACTH release induced by secretagogues. The lipoxygenase inhibitors nordihydroguaieretic acid, butylated hydroxytoluene, and icosatetraynoic acid abolished the ACTH secretion induced by secretagogues, whereas indomethacin, a cycloxygenase inhibitor, did not. Blockers of the cytochrome P-450 epoxygenase, such as SKF 525A and piperonyl butoxide, compounds that have different molecular structures, also suppressed secretagogue-induced ACTH release. These findings suggest that metabolites of arachidonic acid formed via the epoxygenase and/or the lipoxygenase pathway are involved in the stimulation of ACTH release caused by secretagogues.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Axelrod J., Reisine T. D. Stress hormones: their interaction and regulation. Science. 1984 May 4;224(4648):452–459. doi: 10.1126/science.6143403. [DOI] [PubMed] [Google Scholar]
- Capdevila J., Chacos N., Falck J. R., Manna S., Negro-Vilar A., Ojeda S. R. Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence. Endocrinology. 1983 Jul;113(1):421–423. doi: 10.1210/endo-113-1-421. [DOI] [PubMed] [Google Scholar]
- Chacos N., Falck J. R., Wixtrom C., Capdevila J. Novel epoxides formed during the liver cytochrome P-450 oxidation of arachidonic acid. Biochem Biophys Res Commun. 1982 Feb 11;104(3):916–922. doi: 10.1016/0006-291x(82)91336-5. [DOI] [PubMed] [Google Scholar]
- Falck J. R., Manna S., Moltz J., Chacos N., Capdevila J. Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets. Biochem Biophys Res Commun. 1983 Jul 29;114(2):743–749. doi: 10.1016/0006-291x(83)90843-4. [DOI] [PubMed] [Google Scholar]
- Flower R. J., Blackwell G. J. The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol. 1976 Feb 1;25(3):285–291. doi: 10.1016/0006-2952(76)90216-1. [DOI] [PubMed] [Google Scholar]
- Fürstenberger G., Richter H., Fusenig N. E., Marks F. Arachidonic acid and prostaglandin E2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell line. Cancer Lett. 1981 Jan;11(3):191–198. doi: 10.1016/0304-3835(81)90107-5. [DOI] [PubMed] [Google Scholar]
- Hamberg M. On the formation of thromboxane B2 and 12l-hydroxy-5,8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pig. Biochim Biophys Acta. 1976 Jun 22;431(3):651–654. doi: 10.1016/0005-2760(76)90232-0. [DOI] [PubMed] [Google Scholar]
- Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heisler S., Reisine T. D., Hook V. Y., Axelrod J. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6502–6506. doi: 10.1073/pnas.79.21.6502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirata F., Corcoran B. A., Venkatasubramanian K., Schiffmann E., Axelrod J. Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2640–2643. doi: 10.1073/pnas.76.6.2640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hook V. Y., Heisler S., Axelrod J. Corticotropin-releasing factor stimulates phospholipid methylation and corticotropin secretion in mouse pituitary tumor cells. Proc Natl Acad Sci U S A. 1982 Oct;79(20):6220–6224. doi: 10.1073/pnas.79.20.6220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hook V. Y., Heisler S., Sabol S. L., Axelrod J. Corticotropin releasing factor stimulates adrenocorticotropin and beta-endorphin release from AtT-20 mouse pituitary tumor cells. Biochem Biophys Res Commun. 1982 Jun 30;106(4):1364–1371. doi: 10.1016/0006-291x(82)91264-5. [DOI] [PubMed] [Google Scholar]
- Levine L., Hassid A. Effects of phorbol-12,13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem Biophys Res Commun. 1977 Nov 21;79(2):477–484. doi: 10.1016/0006-291x(77)90182-6. [DOI] [PubMed] [Google Scholar]
- Markus H. B., Ball E. G. Inhibition of lipolytic processes in rat adipose tissue by antimalaria drugs. Biochim Biophys Acta. 1969 Dec 17;187(4):486–491. doi: 10.1016/0005-2760(69)90045-9. [DOI] [PubMed] [Google Scholar]
- Mitchell S., Poyser N. L., Wilson N. H. Effect of p-bromophenacyl bromide, an inhibitor of phospholipase A2, on arachidonic acid release and prostaglandin synthesis by the guinea-pig uterus in vitro. Br J Pharmacol. 1977 Jan;59(1):107–113. doi: 10.1111/j.1476-5381.1977.tb06983.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mufson R. A., DeFeo D., Weinstein I. B. Effects of phorbol ester tumor promoters on arachidonic acid metabolism in chick embryo fibroblasts. Mol Pharmacol. 1979 Sep;16(2):569–578. [PubMed] [Google Scholar]
- Nebert D. W., Negishi M. Multiple forms of cytochrome P-450 and the importance of molecular biology and evolution. Biochem Pharmacol. 1982 Jul 15;31(14):2311–2317. doi: 10.1016/0006-2952(82)90523-8. [DOI] [PubMed] [Google Scholar]
- Panganamala R. V., Miller J. S., Gwebu E. T., Sharma H. M., Cornwell D. G. Differential inhibitory effects of vitamin E and other antioxidants on prostaglandin synthetase, platelet aggregation and lipoxidase. Prostaglandins. 1977 Aug;14(2):261–271. doi: 10.1016/0090-6980(77)90171-x. [DOI] [PubMed] [Google Scholar]
- Paul S. M., Axelrod J., Diliberto E. J., Jr Catechol estrogen-forming enzyme of brain: demonstration of a cytochrome p450 monooxygenase. Endocrinology. 1977 Nov;101(5):1604–1610. doi: 10.1210/endo-101-5-1604. [DOI] [PubMed] [Google Scholar]
- Phillips M., Tashjian A. H., Jr Characterization of an early inhibitory effect of glucocorticoids on stimulated adrenocorticotropin and endorphin release from a clonal strain of mouse pituitary cells. Endocrinology. 1982 Mar;110(3):892–900. doi: 10.1210/endo-110-3-892. [DOI] [PubMed] [Google Scholar]
- Shier W. T. Activation of high levels of endogenous phospholipase A2 in cultured cells. Proc Natl Acad Sci U S A. 1979 Jan;76(1):195–199. doi: 10.1073/pnas.76.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Testa B., Jenner P. Inhibitors of Cytochrome P-450s and their mechanism of action. Drug Metab Rev. 1981;12(1):1–117. doi: 10.3109/03602538109011082. [DOI] [PubMed] [Google Scholar]
- Vallee E., Gougat J., Navarro J., Delahayes J. F. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors. J Pharm Pharmacol. 1979 Sep;31(9):588–592. doi: 10.1111/j.2042-7158.1979.tb13597.x. [DOI] [PubMed] [Google Scholar]
- Vargaftig B. B., Hai N. D. Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin. J Pharm Pharmacol. 1972 Feb;24(2):159–161. doi: 10.1111/j.2042-7158.1972.tb08953.x. [DOI] [PubMed] [Google Scholar]